These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 7336095)
21. [Biochemical and electronoptic study on the possible effect of silymarin on ethanol-induced liver damage in rats]. Platt D; Schnorr B Arzneimittelforschung; 1971 Aug; 21(8):1206-8. PubMed ID: 5110020 [No Abstract] [Full Text] [Related]
22. [Effectiveness of legalon and essentiale in a tetracycline-induced liver lesion]. Skakun NP; Stepanova NIu Antibiot Med Biotekhnol; 1986 Oct; 31(10):781-4. PubMed ID: 3789688 [TBL] [Abstract][Full Text] [Related]
23. Hepatoprotective activity of silymarin against hepatic damage in Mastomys natalensis infected with Plasmodium berghei. Chander R; Kapoor NK; Dhawan BN Indian J Med Res; 1989 Dec; 90():472-7. PubMed ID: 2697691 [TBL] [Abstract][Full Text] [Related]
24. Inhibition, by drugs, of galactosamine induced hepatitis in the rat. Pickering RW; Lynn James GW; Parker FL Arzneimittelforschung; 1975 Oct; 25(10):1591-2. PubMed ID: 1243044 [TBL] [Abstract][Full Text] [Related]
27. [Structure of the liver after correction of experimental chronic hepatitis with benzonal and potassium orotate]. Baĭbekova EM; Sultanova LI Arkh Anat Gistol Embriol; 1990 Feb; 98(2):88-94. PubMed ID: 2353891 [TBL] [Abstract][Full Text] [Related]
30. [Silymarin in the prevention of hepatic damage by psychopharmacologic drugs. Experimental premises and clinical evaluations]. Carrescia O; Benelli L; Saraceni F; Braga PC; Cagnetta G; Copponi V Clin Ter; 1980 Oct; 95(2):157-64. PubMed ID: 7471652 [No Abstract] [Full Text] [Related]
31. [Immunomodulator effect of silymarin therapy in chronic alcoholic liver diseases]. Deák G; Müzes G; Láng I; Niederland V; Nékám K; Gonzalez-Cabello R; Gergely P; Fehér J Orv Hetil; 1990 Jun; 131(24):1291-2, 1295-6. PubMed ID: 2195425 [TBL] [Abstract][Full Text] [Related]
32. [The use of silymarin in patients with toxic and viral liver diseases]. Matveev AV; Koniaeva EI Eksp Klin Gastroenterol; 2011; (5):84-90. PubMed ID: 21916240 [TBL] [Abstract][Full Text] [Related]
33. [Effect of antihepatotoxic tea on the course of drug-induced hepatitis]. Ubeeva IP; Nikolaev SM; Sambueva ZG Antibiot Khimioter; 1989 Nov; 34(11):859-62. PubMed ID: 2633705 [TBL] [Abstract][Full Text] [Related]
34. [Constituents of Silybum marianum and their therapeutic use]. Morelli I Boll Chim Farm; 1978 May; 117(5):258-67. PubMed ID: 743375 [No Abstract] [Full Text] [Related]
35. [Action of hepatoprotective agents in a tetracycline lesion of the liver]. Porokhniak LA; Drogovoz SM; Rogozhin BA Antibiot Med Biotekhnol; 1987 Apr; 32(4):282-5. PubMed ID: 3631934 [TBL] [Abstract][Full Text] [Related]
36. [Antihepatoxic effect of silymarin on the disordered phospholipid metabolism due to phalloidine intoxication in rats]. Schriewer H; Rauen HM Hoppe Seylers Z Physiol Chem; 1972 Oct; 353(10):1567-8. PubMed ID: 4649836 [No Abstract] [Full Text] [Related]
37. Effect of partial hepatectomy on the hepatotoxicity of D-galactosamine. Andreicuţ S; Kerekes M Morphol Embryol (Bucur); 1982; 28(2):177-84. PubMed ID: 6213854 [No Abstract] [Full Text] [Related]
38. [Drug clinics. Drug of the month. Legalon (silymarin)]. Luyckx F; Scheen AJ Rev Med Liege; 1997 Dec; 52(12):792-6. PubMed ID: 9481179 [No Abstract] [Full Text] [Related]